OTCMKTS:EMHTF - Emerald Health Therapeutics Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.15
+0.30 (1.20%)

This chart shows the closing price for EMHTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Emerald Health Therapeutics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EMHTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EMHTF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Emerald Health Therapeutics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.15.

This chart shows the closing price for EMHTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Emerald Health Therapeutics. This rating has held steady since February 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/25/2019Jefferies Financial GroupInitiated CoverageHold
(Data available from 7/28/2016 forward)
Emerald Health Therapeutics logo
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production and sale of medical cannabis for medical purpose in Canada. It offers dried cannabis strains, pre-rolls, ingestible extracts, and cannabis oil products to its medical patients. The company distributes its medical products through licensed wholesale pharmacies and to licensed wholesale clients. It also exports medical cannabis products to licensed wholesale purchasers in Europe. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $0.15
Low: $0.14
High: $0.15

50 Day Range

MA: $0.17
Low: $0.14
High: $0.20

52 Week Range

Now: $0.15
Low: $0.12
High: $0.47

Volume

15,857 shs

Average Volume

416,029 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Emerald Health Therapeutics?

The following equities research analysts have issued reports on Emerald Health Therapeutics in the last year:
View the latest analyst ratings for EMHTF.

What is the current price target for Emerald Health Therapeutics?

0 Wall Street analysts have set twelve-month price targets for Emerald Health Therapeutics in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Emerald Health Therapeutics in the next year.
View the latest price targets for EMHTF.

What is the current consensus analyst rating for Emerald Health Therapeutics?

Emerald Health Therapeutics currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for EMHTF.

What other companies compete with Emerald Health Therapeutics?

How do I contact Emerald Health Therapeutics' investor relations team?

The company's listed phone number is (800) 757-3536. The official website for Emerald Health Therapeutics is www.emerald.care.